Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 46.73% vs 80.65% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 43.25% vs 108.32% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 17.16% vs -5.48% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 35.53% vs 112.47% in Mar 2025
Compare Profit and Loss Results of Anlon Healthcare
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
176.00
502.00
-326.00
-64.94%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
176.00
502.00
-326.00
-64.94%
Expenditure (Ex Depriciation)
Stock Adjustments
-16.00
-2.00
-14.00
-700.00%
Raw Materials Consumed
129.00
247.00
-118.00
-47.77%
Power & Fuel Cost
3.00
3.00
0.00
0.00%
Employee Cost
5.00
63.00
-58.00
-92.06%
Operating Expenses
3.00
7.00
-4.00
-57.14%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
80.00
-80.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
2.00
5.00
-3.00
-60.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
130.00
426.00
-296.00
-69.48%
Operating Profit (PBDIT) excl Other Income
46.00
75.00
-29.00
-38.67%
Other Income
0.00
17.00
-17.00
-100.00%
Operating Profit (PBDIT)
46.00
93.00
-47.00
-50.54%
Interest
4.00
0.00
4.00
0%
Profit before Depriciation and Tax
42.00
93.00
-51.00
-54.84%
Depreciation
1.00
6.00
-5.00
-83.33%
Profit Before Taxation & Exceptional Items
40.00
86.00
-46.00
-53.49%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
40.00
77.00
-37.00
-48.05%
Provision for Tax
12.00
19.00
-7.00
-36.84%
Profit After Tax
27.00
57.00
-30.00
-52.63%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
23.00
272.00
-249.00
-91.54%
Profit Available for appropriations
50.00
330.00
-280.00
-84.85%
Appropriations
50.00
330.00
-280.00
-84.85%
Equity Dividend (%)
0%
490%
-490.00
Earnings Per Share
5.84
20.03
-14.19
-70.84%
Profit And Loss - Net Sales
Net Sales 176.50 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 46.73% vs 80.65% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 46.14 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 43.25% vs 108.32% in Mar 2025
Profit And Loss - Interest
Interest 4.35 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 17.16% vs -5.48% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 27.81 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 35.53% vs 112.47% in Mar 2025
